Kato, Takeshi
Kudo, Toshihiro http://orcid.org/0000-0003-3584-6375
Kagawa, Yoshinori
Murata, Kohei
Ota, Hirofumi
Noura, Shingo
Hasegawa, Junichi
Tamagawa, Hiroshi
Ohta, Katsuya
Ikenaga, Masakazu
Miyazaki, Susumu
Komori, Takamichi
Uemura, Mamoru
Nishimura, Junichi
Hata, Taishi
Matsuda, Chu
Satoh, Taroh
Mizushima, Tsunekazu
Ohno, Yuko
Yamamoto, Hirofumi
Doki, Yuichiro
Eguchi, Hidetoshi
Article History
Received: 12 July 2022
Accepted: 9 November 2022
First Online: 9 February 2023
Competing interests
: This study was funded by Bayer Yakuhin, Ltd. Toshihiro Kudo was associated with a donated fund laboratory of Yakult Honsha Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; and Ono Pharmaceutical Co., Ltd. and received lecture fees from Chugai Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Eli Lilly Japan Co., Ltd.; Bayer Yakuhin, Ltd.; Sanofi Co., Ltd.; Taiho Pharmaceutical Co., Ltd.; Merck Biopharma Co., Ltd.; and Takeda Pharmaceutical Co., Ltd. The other authors have no conflict of interest to declare.